2026 NPPES data Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist NPI 1508131509 MD
Verify on CMS →

David Remy, MD

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist in Tulsa, Oklahoma.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 14,139 in Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 220 beneficiaries · Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist avg: 231
Generic prescribing
77%
generic claims · 23% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
85.8/100
▲ 2 pts above national avg 83.5 · Above neutral

What the federal data shows

David Remy, MD reported a CMS MIPS final score of 85.8/100 - above the 83.5 national average - and filed 3,496 Medicare Part D claims in 2024.

85.8/100
MIPS score · +2 vs avg
3K
Part D claims, 2024
77%
generic prescribing
≥46th
pct among measured MIPS (lower-bound band)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about David Remy, MD

Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1508131509), first enumerated 03/09/2012.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 3,496 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    CMS quality reporting (MIPS)

    Reported a CMS MIPS final score of 85.8/100 in the Quality Payment Program — a federal quality measure, not a patient review.

    Source: CMS Quality Payment Program

  • Reported

    Hospital affiliations

    2 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

Compare Remy with other Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist providers

Same primary specialty, same federal CMS NPPES roster.

Also enrolled in Oklahoma

Other specialties in Tulsa: Case Manager/Care Coordinator (2,118) · Student in an Organized Health Care Education/Training Program (1,898) · Peer Specialist (911) · Counselor (888)

CMS NPPES provider registry desk

NPI 1508131509 · Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist

NPI-10 · ENUM-MID · TAX-MID · MIPS-INLINE · RX-MID · BOOK-THIN · NEAR-MIPS

  • NPI-10 1508131509
  • ENUM-MID 2012
  • TAX-MID 14K Pharmacist Clinician
  • MIPS-INLINE 85.8/100
  • RX-MID 3,496
  • BOOK-THIN 101 in Oklahoma
  • NEAR-MIPS Christopher Burns, P… · 3.6

David Remy, MD's MIPS score vs every measured U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.

86 ≥ 46th percentile 46% of 454,083 measured providers are in lower value bands

0–10: 8,684 measured providers (2%). Below this entry. 10–20: 3,008 measured providers (1%). Below this entry. 20–30: 3,069 measured providers (1%). Below this entry. 30–40: 2,746 measured providers (1%). Below this entry. 40–50: 2,928 measured providers (1%). Below this entry. 50–60: 5,882 measured providers (1%). Below this entry. 60–70: 13,906 measured providers (3%). Below this entry. 70–80: 94,570 measured providers (21%). Below this entry. 80–90: 129,887 measured providers (29%). This entry sits in this band. 90+: 189,403 measured providers (42%). Above this entry. This provider 0 100 every measured MIPS clinician, bucketed by value

Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

What does the federal data show about David Remy, MD?

High performer (top quartile)

NPI registry status

Active

Issued 03/09/2012

NPI 1508131509

Primary specialty

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist

Mid-sized

14,139 US NPIs in this specialty

Medicare Part D claims

3,496 15× vs specialty avg

2024 prescription claims

Specialty avg: 231

MIPS final score

85.8/100 2.3 pts vs avg

Above neutral band

vs 83.5 national avg

Specialty distribution in Oklahoma

How Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist compares to other specialties among Oklahoma providers

Oklahoma providers
Case Manager/Care Coordinator9.6%Mental Health Counselor7%Behavior Technician6.6%Peer Specialist5.6%Counselor4.9%Student in an Organized Heal…4.2%Pharmacist Clinician (PhC)/ …0.1%
Largest specialties in Oklahoma (% of in-state providers)

Medicare quality performance, MIPS

David Remy, MD's 2023 MIPS final score plotted against the Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist national average

High performer (top quartile)
MIPS Final Score
85.8/100
vs 83.5 national avg · 2023 performance year
0%100%National avg84%85.8%
MIPS final score (Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist) - 85.8/100 vs national avg 83.5
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

1717 S UTICA AVE STE A
Tulsa, OK 74104

Provider Details

NPI 1508131509
Specialty Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Credentials MD
Gender Male
NPI Issued 03/09/2012

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

85.8356
Final Score
Measured-score avg: 83.5
90.7464
Quality
51.9578
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where David Remy, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Glendale Adventist Emergency Physicians Incorporated
Glendale, CA
LA Jolla Medical Group Inc
Los Angeles, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Brand vs generic prescribing mix · Typical

David Remy, MD - brand share 23.0%
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist average

23% brand-name claims vs 77% generic, on 3,496 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

3,496
Total Claims
$652K
Total Drug Cost
220
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
3,994.8
Total Day Supply
113,539
Brand vs Generic
23% brand / 77% generic
Brand Drug Cost
$421K
Generic Drug Cost
$230K
Opioid Claims
57 (1.6% rate)
Antibiotic Claims
140

Patient Demographics

Average Patient Age
72.8 years
Avg HCC Risk Score
1.66
Gender Split
62% female / 38% male
Age Distribution
<65: 38, 65-74: 84, 75-84: 65, 85+: 33

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What David Remy, MD prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Dexlansoprazole Dr
Dexlansoprazole
111
Amlodipine Besylate
106
Metformin Hcl
93
Rosuvastatin Calcium
92
Atorvastatin Calcium
77
Hydrochlorothiazide
66
Linzess
Linaclotide
65
Allopurinol
63
Diclofenac Sodium
60
Myrbetriq
Mirabegron
56

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Overview

How David Remy, MD fits within the Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist landscape nationally.

14,139
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Providers in US
55
States with Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
231
Avg Claims per Provider

David Remy, MD's 3,496 claims are above the specialty average of 231.

Nationwide Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist peers with similar MIPS or enrollment year

Two federal-record peer sets for Remy, both outside Oklahoma so the neighborhoods are not geographic containment.

Similar MIPS final score

Nearest same-specialty clinicians by CMS MIPS final score (85.8 here).

Same NPPES enumeration year (2012)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist Providers in Oklahoma

Other clinicians with the same primary specialty enrolled in Oklahoma, drawn from the same CMS NPPES roster as Remy.

One of 101 Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist providers enrolled in Oklahoma, 11 are shown on this page.

Compare Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is David Remy, MD's specialty? ▼
David Remy, MD specializes in Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist and practices in Tulsa, Oklahoma. Credentials: MD.
How much does David Remy, MD prescribe under Medicare Part D? ▼
In 2024, David Remy, MD wrote 3,496 Medicare Part D claims totaling $652K in drug costs for 220 beneficiaries.
What is David Remy, MD's Medicare quality score? ▼
David Remy, MD has a CMS MIPS Final Score of 85.8/100 (Quality: 90.7, Cost: 52). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is David Remy, MD located? ▼
David Remy, MD is located at 1717 S UTICA AVE STE A, Tulsa, OK, 74104. Phone: (918) 744-2630.
What is David Remy, MD's NPI number? ▼
David Remy, MD's National Provider Identifier (NPI) is 1508131509, issued on 03/09/2012.
Does David Remy, MD prescribe more brand-name or generic drugs? ▼
David Remy, MD's prescribing is 23% brand-name and 77% generic drugs by claim count, with $421K in brand drug costs.
Does David Remy, MD prescribe opioids? ▼
Yes, David Remy, MD had 57 opioid claims in 2024 with an opioid prescribing rate of 1.6%.
How many Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist providers are there in the US? ▼
There are 14,139 Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist providers across 55 states in the US. The average Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist provider writes 231 Medicare Part D claims per year.
What drugs does David Remy, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, David Remy, MD's most frequently prescribed drugs include Dexlansoprazole Dr, Amlodipine Besylate, Metformin Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does David Remy, MD accept Medicare? ▼
David Remy, MD appears in CMS Medicare data with 3,496 Part D claims and 220 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify David Remy, MD's credentials? ▼
David Remy, MD's NPI is 1508131509 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.